Skip to main content
OpenTrials
Completed

NCT Number: NCT06035926

Survey of Symptoms After a COVID Vaccination in Employees

Background:

SARS-CoV-2 (Severe acute respiratory syndrome coronavirus type 2) has had us firmly in its grip for more than two years. In January 2021, the quality and risk management unit of the LKH (Landeskrankenhaus) -Univ. Klinikum Graz commissioned to carry out vaccinations for employees and subsequently for high-risk patients.

In the vaccination line, which was open for 85 days in 2021/22, the vaccines from Astra Zeneca, Biontech-Pfizer and Moderna were vaccinated. There were hardly any complications. The primary immunization, booster vaccination and booster vaccination were carried out.

Despite the small number of incidents in the sense of an immediate reaction, there were numerous sick leave.

Methods:

For this reason, in the course of the booster vaccination, starting from October 2021 to January 2022, every vaccinated person was asked to fill out a questionnaire. Participation was voluntary and was supported by the works councils of the Medical University and the LKH-University clinic Graz approved. The survey served to retrospectively record how many employees developed symptoms in response to the respective vaccination.

With this approach it will be possible to subject the responses to an in-depth statistical analysis in order to obtain a data-based contribution to the side effects of vaccines categorized with different vaccination schemes.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Symptoms Recoding SARS-CoV-2 After Vaccination

Age range

16 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Medical University of Graz

Graz, Styria, 8036, Austria

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Employees with appropriate indication (>4 months after the second vaccination) according to the recommendations of the national vaccination committee.
  • Signed vaccination information sheet.

Exclusion criteria

  • no booster vaccination.

Treatment and study plan

Questionnaire

Other

questionnaire

Primary outcomes

  1. Occurrence of symptoms after the respective vaccination

    Time frame: 10 Minutes

    Occurence of symptoms, assessed by a questionnaire

Sponsors and collaborators

Lead sponsor

Medical University of Graz

Other

Registry information

Official study title

Survey of Symptoms After a COVID Vaccination in Employees: a Retrospective Study.

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
Sep 13, 2023
Registry last updated
Sep 13, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.